Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with alzheimer's disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 121 B, Issue 1, 2003, Pages 128-130

  Kölsch, Heike ^a   Ptok, Ursula ^a   Mohamed, Iman ^a   Schmitz, Sandra ^a   Rao, Marie Luise ^a   Maier, Wolfgang ^a   Heun, Reinhard ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Apolipoprotein E; Association; Chromosome 12; LRP

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0042821639     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20043     Document Type: Article

References (21)

1. Baum L, Chen L, Ng HK, Chan YS, Mak YT, Woo J, Chiu HFK, Pang CP. 1998. Low density lipoprotein receptor-related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett 247:33-36.
2. Beffert U, Arguin C, Poirier J. 1999. The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease. Neurosci Lett 259:29-32.
3. Benes P, Muzik J, Benedik J, Elbl L, Vasku A, Siskova L, Znojil V, Vacha J. 2001. The C766T low-density lipoprotein receptor-related protein polymorphism and coronary artery disease, plasma lipoproteins, and longevity in the Czech population. J Mol Med 79:116-120.
4. Bullido MJ, Guallar-Castillon P, Artiga MJ, Ramos MC, Sastre I, Aldudo J, Frank A, Coria F, Rodriguez-Artalejo F, Valdivieso F. 2000. Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor-related protein polymorphisms: Absence of genetic interactions, and modulation by gender. Neurosci Lett 289:213-216.
5. Citron M, Westway D, Weiming X, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motier R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, Hyslop PG, Selkoe DJ. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3:67-72.
6. Fassbender K, Simons M, Bergmann C, Stroick M, Lütjohann D, Keller P, Runz H, Kuhl S, Bertsch T, Von Bergmann K, Hennerici M, Beyreuther K, Hartmann T. 2001. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 98:5856-5861.
7. Goate AM. 1998. Monogenetic determinants of Alzheimer's disease: APP mutations. Cell Mol Life Sci 54:897-901.
8. Hatanaka Y, Kamino K, Fukuo K, Mitsuda N, Nishiwaki-Ueda Y, Sato N, Satoh T, Yamamoto H, Yoneda H, Imagawa M, Miki T, Ohta S, Ogihara T. 2000. Low density lipoprotein receptor-related protein gene poly-morphisms and risk for late-onset Alzheimer's disease in a Japanese population. Clin Genet 58:319-323.
9. Hixson JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548.
10. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. 2000. Statins and the risk of dementia. Lancet 356:1627-1631.
11. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R. 1997. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49:56-61.
12. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. 2001. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. BMJ 322:1447-1451.
13. Lambert JC, Wavrant-De Vrieze F, Amouyel P, Chartier-Harlin MC. 1998. Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet 351:1787-1788.
14. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto A, Nissinen A. 1998. Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease. Neuroepidemiology 17:14-20.
15. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV. 2000. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489-1499.
16. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. 1998. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460-6464.
17. Song J, Hong SH, Min W, Kim JQ. 2000. Association between triglyceriderich lipoprotein remnant receptor polymorphisms and lipid traits. Clin Biochem 33:441-447.
18. Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgraber D, Roses AD. 1993. Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102.
19. Tooyama I, Kawamata T, Akiyama H, Kimura H, Moestrup SK, Gliemann J, Matsuo A, McGeer PL. 1995. Subcellular localization of the low density lipoprotein receptor-related protein (alpha 2-macroglobulin receptor) in human brain. Brain Res 691:235-238.
20. Wolf BB, Lopes MB, VandenBerg SR, Gonias SL. 1992. Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol 141:37-42.
21. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439-1443.